Palmitate causes endoplasmic reticulum stress and apoptosis in human mesenchymal stem cells: Prevention by AMPK activator

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5275-5284

  Lu, Jun ^a   Wang, Qinghua ^a   Huang, Lianghu ^a   Dong, Huiyue ^a   Lin, Lingjing ^a   Lin, Na ^a   Zheng, Feng ^a   Tan, Jianming ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 4; AMINOIMIDAZOLE CARBOXAMIDE RIBONUCLEOTIDE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; INITIATION FACTOR 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PALMITIC ACID; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA SPLICING; UMBILICAL CORD;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; HUMANS; HYPOGLYCEMIC AGENTS; MESENCHYMAL STROMAL CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PALMITIC ACID; PHOSPHORYLATION; RIBONUCLEOTIDES;

EID: 84867795111     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1418     Document Type: Article

References (40)

1. Cunha DA, Hekerman P, Ladrière L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E, Overbergh L, Mathieu C, Lupi R, Hai T, Herchuelz A, Marchetti P, Rutter GA, Eizirik DL, Cnop M 2008 Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121:2308-2318
2. Leroy C, Tricot S, Lacour B, Grynberg A 2008 Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta 1781:685-693
3. Jiang H, Liang C, Liu X, Jiang Q, He Z, Wu J, Pan X, Ren Y, Fan M, Li M, Wu Z 2010 Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways. Atherosclerosis 210:71-77
4. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ 2007 Endoplasmic reticulum stress contributes to β-cell apoptosis in type 2 diabetes. Diabetologia 50:752-763 (Pubitemid 46355827)
5. Ye J 2007 Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 7:65-74 (Pubitemid 46380417)
6. Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M, Volchuk A 2008 Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic β-cells. Am J Physiol Endocrinol Metab 294:E540-E550 (Pubitemid 351355224)
7. Martinez SC, Tanabe K, Cras-Méneur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA 2008 Inhibition of Foxo1 protects pancreatic islet β-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57:846-859
8. Cunha DA, Ladrière L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R, Marchetti P, Eizirik DL, Cnop M 2009 Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58:2851-2862
9. Marchetti P, Bugliani M, Lupi R, Marselli L, Masini M, Boggi U, Filipponi F, Weir GC, Eizirik DL, Cnop M 2007 The endoplasmic reticulum in pancreatic β-cells of type 2 diabetes patients. Diabetologia 50:2486-2494 (Pubitemid 350060637)
10. Ron D, Walter P 2007 Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529 (Pubitemid 46985379)
11. Eizirik DL, Cardozo AK, Cnop M 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61 (Pubitemid 351252746)
12. Misra P, Chakrabarti R 2007 The role of AMP kinase in diabetes. Indian J Med Res 125:389-398 (Pubitemid 46805453)
13. Boyle JG, Salt IP, McKay GA 2010 Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 27:1097-1106
14. Carling D, Mayer FV, Sanders MJ, Gamblin SJ 2011 AMP-activated protein kinase: nature's energy sensor. Nat Chem Biol 7:512-518
15. Kim JE, Kim YW, Lee IK, Kim JY, Kang YJ, Park SY 2008 AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-β-D- ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. J Pharmacol Sci 106:394-403
16. Mayer CM, Belsham DD 2010 Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5′ monophosphate-activated protein kinase activation. Endocrinology 151:576-585
17. Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M 2011 Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 29:5-10
18. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML 2010 Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667-679
19. Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WE 2011 Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 29:169-178
20. Stolzing A, Sellers D, Llewelyn O, Scutt A 2010 Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 191:453-465
21. Yang K, Wang XQ, He YS, Lu L, Chen QJ, Liu J, Shen WF 2010 Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol 9:66
22. Boden G 2011 Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18:139-143
23. Ramos CA, Asgari Z, Liu E, Yvon E, Heslop HE, Rooney CM, Brenner MK, Dotti G 2010 An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells 28:1107-1115
24. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC 2004 Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337
25. Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C 2012 Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307:1169-1177
26. Lu J, Li G, Lan MS, Zhang S, Fan W, Wang H, Lu D 2007 Pax4 paired domain mediates direct protein transduction into mammalian cells. Endocrinology 148:5558-5565 (Pubitemid 350012639)
27. Yuzefovych LV, Solodushko VA, Wilson GL, Rachek LI 2012 Protection from palmitate-induced mitochondrial DNA damage prevents from mitochondrial oxidative stress, mitochondrial dysfunction, apoptosis, and impaired insulin signaling in rat l6 skeletal muscle cells. Endocrinology 153:92-100
28. Kim JE, Ahn MW, Baek SH, Lee IK, Kim YW, Kim JY, Dan JM, Park SY 2008 AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone 43:394-404
29. Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, Wu M, Choi HC, Lyons TJ, Zou MH 2010 Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59:1386-1396
30. Fibbe WE, Noort WA 2003 Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann NY Acad Sci 996:235-244 (Pubitemid 36706606)
31. Kent S 1976 Is diabetes a form of accelerated aging? Geriatrics 31:140, 145, 149-151
32. Boden G, Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14-23 (Pubitemid 41704996)
33. Lim S, Jang HJ, Park EH, Kim JK, Kim JM, Kim EK, Yea K, Kim YH, Lee-Kwon W, Ryu SH, Suh PG 7 June 2012 Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 10.1002/jcb.24220
34. Zarubin T, Han J 2005 Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18 (Pubitemid 41653958)
35. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, Yoneda T 2003 Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor γ during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14:545-555 (Pubitemid 36237015)
36. Bhandari DR, Seo KW, Roh KH, Jung JW, Kang SK, Kang KS 2010 REX-1 expression and p38 MAPK activation status can determine proliferation/ differentiation fates inhumanmesenchymal stem cells. PLoS One 5:e10493
37. Verma G, Datta M 2011 The critical role of JNK in the ER-mitochondrial crosstalk during apoptotic cell death. J Cell Physiol 227:1791-1795
38. Kim J, Park YJ, Jang Y, Kwon YH 2011 AMPK activation inhibits apoptosis and tau hyperphosphorylation mediated by palmitate in SH-SY5Y cells. Brain Res 1418:42-51
39. Cacicedo JM, Benjachareonwong S, Chou E, Yagihashi N, Ruderman NB, Ido Y 2011 Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes. Invest Ophthalmol Vis Sci 52:3630-3639
40. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, Hirota H 2005 AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25:9554-9575 (Pubitemid 41507855)